Stocks
Funds
Screener
Sectors
Watchlists
GDRX

GDRX - GoodRx Holdings Inc Stock Price, Fair Value and News

$2.34+0.01 (+0.43%)
Market Closed

43/100

GDRX

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

43/100

GDRX

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$2.31

Target 3M

$2.49

Target 6M

$2.43

GDRX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

GDRX Price Action

Last 7 days

-9.3%

Last 30 days

-13.0%

Last 90 days

-32.0%

Trailing 12 Months

-52.1%

GDRX RSI Chart

GDRX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

GDRX Valuation

Market Cap

844.1M

Price/Earnings (Trailing)

26.58

Price/Sales (Trailing)

1.05

EV/EBITDA

7.82

Price/Free Cashflow

4.76

GDRX Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$2.31

Target 3M

$2.49

Target 6M

$2.43

GDRX Fundamentals

GDRX Revenue

Revenue (TTM)

800.7M

Rev. Growth (Yr)

0.4%

Rev. Growth (Qtr)

-3.47%

GDRX Earnings

Earnings (TTM)

31.8M

Earnings Growth (Yr)

-71.78%

Earnings Growth (Qtr)

-91.29%

GDRX Profitability

EBT Margin

6.71%

Return on Equity

5.29%

Return on Assets

2.4%

Free Cashflow Yield

21.01%

GDRX Investor Care

Buy Backs (1Y)

6.43%

Diluted EPS (TTM)

0.09

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025797.4M799.9M800.7M0
2024764.2M775.1M790.4M792.3M
2023747.2M745.1M737.7M750.3M
2022788.3M803.5M795.7M766.6M
2021577.7M631.1M685.7M745.4M
2020428.8M469.5M510.1M550.7M
201900318.9M388.2M
2018000249.5M
GDRX
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. GoodRx Holdings, Inc. was incorporated in 2015 and is headquartered in Santa Monica, California.
 WEBSITEgoodrx.com
 SECTORHealthcare
 INDUSTRYHealth Information Services
 EMPLOYEES952

GoodRx Holdings Inc Frequently Asked Questions


GDRX is the stock ticker symbol of GoodRx Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of GoodRx Holdings Inc is 844.15 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check GDRX's fair value in chart for subscribers.

The fair value guage provides a quick view whether GDRX is over valued or under valued. Whether GoodRx Holdings Inc is cheap or expensive depends on the assumptions which impact GoodRx Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for GDRX.

As of Wed Jan 28 2026, GDRX's PE ratio (Price to Earnings) is 26.58 and Price to Sales (PS) ratio is 1.05. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. GDRX PE ratio will change depending on the future growth rate expectations of investors.